| P2093 | author name string | Stefan Hajdu | |
| | Wolfgang Graninger | |
| | Elisabeth Presterl | |
| | Johannes Holinka | |
| | Alexander M Hirschl | |
| | Andrea M Lassnigg | |
| P2860 | cites work | Effects of alcohols, povidone-iodine and hydrogen peroxide on biofilms of Staphylococcus epidermidis. | Q53544918 |
| | Cost of treating an infected total knee replacement | Q71733723 |
| | Antibiotic susceptibility assay for Staphylococcus aureus in biofilms developed in vitro | Q78165206 |
| | Clinical and microbiologic effects of subgingivally delivered 0.5% azithromycin in the treatment of chronic periodontitis | Q94818864 |
| | Bacterial biofilms: a common cause of persistent infections | Q27861033 |
| | Laboratory, clinical, and epidemiological aspects of coagulase-negative staphylococci | Q30450189 |
| | Clarithromycin destroys biofilms and enhances bactericidal agents in the treatment of Pseudomonas aeruginosa osteomyelitis | Q33211074 |
| | Use of confocal microscopy to analyze the rate of vancomycin penetration through Staphylococcus aureus biofilms | Q33215849 |
| | Evaluation of high-dose daptomycin for therapy of experimental Staphylococcus aureus foreign body infection | Q33239640 |
| | Clinical behavior of implant infections due to Staphylococcus epidermidis. | Q33369580 |
| | Reduced susceptibility of Staphylococcus aureus to vancomycin--a review of current knowledge | Q33633133 |
| | The Calgary Biofilm Device: new technology for rapid determination of antibiotic susceptibilities of bacterial biofilms. | Q33960800 |
| | Long-term azitromycin treatment of cystic fibrosis patients with chronic Pseudomonas aeruginosa infection; an observational cohort study | Q34400784 |
| | Coagulase-negative staphylococci as a cause of infections related to intravascular prosthetic devices: limitations of present therapy | Q34425719 |
| | Efficacy of antiadhesive, antibiotic and antiseptic coatings in preventing catheter-related infections: review | Q34503825 |
| | Concentration of azithromycin in human prostatic tissue | Q34602182 |
| | Pharmacokinetics and tolerability of daptomycin at doses up to 12 milligrams per kilogram of body weight once daily in healthy volunteers | Q35091557 |
| | Effects of subinhibitory concentrations of vancomycin or cefamandole on biofilm production by coagulase-negative staphylococci | Q35249874 |
| | Mechanical circulatory assistance for acute and chronic heart failure: a review of current technology and clinical practice. | Q35591210 |
| | Treatment of infections associated with surgical implants | Q35740678 |
| | Daptomycin susceptibility of unusual gram-positive bacteria: comparison of results obtained by the Etest and the broth microdilution method. | Q35758918 |
| | Azithromycin blocks quorum sensing and alginate polymer formation and increases the sensitivity to serum and stationary-growth-phase killing of Pseudomonas aeruginosa and attenuates chronic P. aeruginosa lung infection in Cftr(-/-) mice | Q36095028 |
| | Engineering approaches for the detection and control of orthopaedic biofilm infections | Q36213823 |
| | Subinhibitory concentrations of azithromycin decrease nontypeable Haemophilus influenzae biofilm formation and Diminish established biofilms | Q36422690 |
| | Biofilm bacteria: formation and comparative susceptibility to antibiotics | Q36500989 |
| | Daptomycin: a review 4 years after first approval | Q36972980 |
| | Adherence of coagulase-negative staphylococci to plastic tissue culture plates: a quantitative model for the adherence of staphylococci to medical devices | Q37283349 |
| | Drug-eluting stents: a comprehensive appraisal | Q37445860 |
| | Azithromycin retards Pseudomonas aeruginosa biofilm formation | Q37703408 |
| | Distribution and antimicrobial activity of fosfomycin in the interstitial fluid of human soft tissues. | Q39475307 |
| | A nanoscale drug-entrapment strategy for hydrogel-based systems for the delivery of poorly soluble drugs. | Q39896845 |
| | Interaction between clarithromycin and biofilms formed by Staphylococcus epidermidis | Q40284837 |
| | Multiple combination bactericidal testing of staphylococcal biofilms from implant-associated infections | Q41762607 |
| | Comparative activities of daptomycin, linezolid, and tigecycline against catheter-related methicillin-resistant Staphylococcus bacteremic isolates embedded in biofilm | Q42845932 |
| | The relationship between inhibition of bacterial adhesion to a solid surface by sub-MICs of antibiotics and subsequent development of a biofilm | Q43185688 |
| | Biofilm testing of Staphylococcus epidermidis clinical isolates: low performance of vancomycin in relation to other antibiotics | Q44288521 |
| | Effects of vancomycin, daptomycin, fosfomycin, tigecycline, and ceftriaxone on Staphylococcus epidermidis biofilms. | Q46035520 |
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Staphylococcus epidermidis | Q131915 |
| | vancomycin | Q424027 |
| | biofilm | Q467410 |
| | azithromycin | Q165399 |
| | ceftriaxone | Q421713 |
| P1104 | number of pages | 6 | |
| P304 | page(s) | 3205-3210 | |
| P577 | publication date | 2009-05-18 | |
| P1433 | published in | Antimicrobial Agents and Chemotherapy | Q578004 |
| P1476 | title | Effects of azithromycin in combination with vancomycin, daptomycin, fosfomycin, tigecycline, and ceftriaxone on Staphylococcus epidermidis biofilms | |
| P478 | volume | 53 | |